![](/img/cover-not-exists.png)
AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
Hickinson, D. M., Klinowska, T., Speake, G., Vincent, J., Trigwell, C., Anderton, J., Beck, S., Marshall, G., Davenport, S., Callis, R., Mills, E., Grosios, K., Smith, P., Barlaam, B., Wilkinson, R. WVolume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-09-2353
Date:
February, 2010
File:
PDF, 880 KB
english, 2010